Pharmacogenetics-Based Warfarin Dosing in Patients With Cardiac Valve Replacement: The Effects of CYP2C9 and VKORC1 Gene Polymorphisms.
about
Pharmacogenetics-Based Warfarin Dosing in Patients With Cardiac Valve Replacement: The Effects of CYP2C9 and VKORC1 Gene Polymorphisms.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Pharmacogenetics-Based Warfari ...... and VKORC1 Gene Polymorphisms.
@en
Pharmacogenetics-Based Warfari ...... and VKORC1 Gene Polymorphisms.
@nl
type
label
Pharmacogenetics-Based Warfari ...... and VKORC1 Gene Polymorphisms.
@en
Pharmacogenetics-Based Warfari ...... and VKORC1 Gene Polymorphisms.
@nl
prefLabel
Pharmacogenetics-Based Warfari ...... and VKORC1 Gene Polymorphisms.
@en
Pharmacogenetics-Based Warfari ...... and VKORC1 Gene Polymorphisms.
@nl
P2093
P2860
P356
P1433
P1476
Pharmacogenetics-Based Warfari ...... and VKORC1 Gene Polymorphisms.
@en
P2093
Abbas Afrasiabirad
Ebrahim Sakhinia
Negin Farzamikia
P2860
P356
10.1093/LABMED/LMX072
P577
2017-11-22T00:00:00Z